News Manufacturing General
August 25, 2020  

UN cautions virus plasma treatment still experimental

WHO considers plasma therapy to be experimental and that it should continue to be evaluated.

News Government General
August 24, 2020  

Trump announces plasma treatment authorized for COVID-19

FDA scientists says plasma should not be considered a new standard of care for the treatment of patients with COVID-19.

News Manufacturing General Operations Production
May 19, 2015  

ProMetic Life Sciences signs Winnipeg plant to process plasma

Emergent BioSolutions facility will process up to 250,000 litres of plasma annually.

News General
May 1, 2013  

ProMetic and SSB expand their plasma purification efforts

Expanded strategic deal includes equipment and co-commercialization.

News Manufacturing Business Operations Operations Technology
October 16, 2012  

ProMetic extends its reach in Asian markets with $21M deal

R&D project will expand Shenzhen Hepalink’s product line and diversification efforts.

News General
August 13, 2012  

ProMetic turns loss around in Q2

Doubles revenues, records a profit of $800,000

News General
July 30, 2012  

ProMetic, NantPharma form US biopharmaceutical company

NantPro will manufacture plasma-derived product for US market.

News Manufacturing Business Operations Facilities Maintenance Operations Technology
June 27, 2012  

ProMetic gets $4.6M Octapharma order

PrioClear prion capture resin is used in plasma product production.

News Business Operations Operations Technology
May 7, 2012  

ProMetic and Hematech close $10M orphan drug deal

ProMetic Life Sciences Inc. in Laval, Que. has signed a $10-million strategic manufacturing and licence deal with a drug manufacturer in Taiwan to co-develop and commercialize a pharma product that targets a rare medical condition (orphan).